New Zealand News
-
NZ firm to raise funds for Australia trial
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 t...Read more
-
LanzaTech secures $15 mn debt financing from WTI
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Singapore: LanzaTech, a pioneer in waste-to-fuels and chemicals technology, closed $15 million in debt financing from W...Read more
-
Asia vaccine strategists call for collaboration
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...Read more
-
Clinical Network Services acquires Beltas' assets
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2013
Singapore: Clinical Network Services (CNS), an Australia-based CRO offering integrated development services in the plann...Read more
-
Clinical Network Services acquires BELTAS' business assets
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Australian CRO, Clinical Network Services (CNS), has acquired the business assets of its erstwhile New Zealan...Read more
-
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 18 May, 2012
Singapore: LanzaTech, a producer of low-carbon fuels and chemicals from waste gases, has for the second year in a row be...Read more
-
5 major policy developments of 2012
New Zealand | Regulatory | By BioSpectrum Bureau | 0 Comment | 20 Dec, 2012
The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken...Read more
-
What the future holds for the APAC CRO market?
New Zealand | Analysis | By BioSpectrum Bureau | 2 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Trial begins for vaccine that builds gluten tolerance
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical tria...Read more
-
New Zealand approves stem cell drug Prochymal
New Zealand | Regulatory | By BioSpectrum Bureau | 4 Comment | 15 Jun, 2012
Singapore: Osiris Therapeutics has received consent from New Zealand to market its first-in-class stem cell therapy Proc...Read more
-
IMCD acquires Aussie pharma distributor
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: Global distribution firm IMCD Group has acquired Capitol Ingredients Australia, a Sydney headquartered specia...Read more
-
NZ Smart device company receives $2.5m fund
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
‎Singapore: Asia Pacific healthcare fund manager, BioScience Managers have plans to make investment of US$2.5 mill...Read more
-
NZ firm to shut bio-diesel unit due to lack of profit
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2012
Singapore: New Zealand-based natural energy provider, Solid Energy (SE), is looking to shut down its biodiesel division....Read more
-
INVISTA and LanzaTech sign biofuel deal
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2012
Singapore: World-leading nylon producer, INVISTA, and biotechnology firm, LanzaTech signed a joint development agreement...Read more
-
Genetic diagnostics companies speed ahead
New Zealand | Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013
The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US...Read more
-
Value Plastics expands with eyes on Asia Pacific
New Zealand | Influencers | By BioSpectrum Bureau | 2 Comment | 28 May, 2012
Colorado-based Value Plastics (VP) a Nordson company, designs, develops and manufactures a standard line of plastic tubi...Read more
